Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transforming growth factor beta-1 proprotein (TGF-β1 proprotein) is a multifunctional cytokine precursor that regulates cell growth, differentiation, and function. It is synthesized as a large precursor that undergoes proteolytic cleavage to generate the latency-associated peptide (LAP) and the mature TGF-β1 peptide. The latent complex of LAP and mature TGF-β1 keeps the cytokine inactive until it is activated by integrins and other factors. Active TGF-β1 signals through serine/threonine kinase receptors, leading to activation of SMAD proteins and regulation of gene expression. TGF-β1 plays a critical role in development, immune regulation, tissue remodeling, and cellular homeostasis, and its dysregulation is implicated in various diseases.
TGF-β1 proprotein itself is not directly targeted by drugs. However, its downstream signaling pathways and activation mechanisms are potential targets. Drugs can be designed to inhibit the interaction of TGF-β1 with its receptors, block the activation of latent TGF-β1, or interfere with the SMAD signaling pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transforming Growth Factor Beta-1 Proprotein (TGF-β1 proprotein).